We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

May 17, 2012

Skelaxin (Metaxalone) Antitrust Litigation

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. December 22, 2015

    Judge Signs Off On $9M Skelaxin Antitrust Settlement

    A Tennessee federal judge gave his final approval Tuesday for a $9 million agreement reached between Mutual Pharmaceutical Co. Inc. and an end-payor class to settle claims the company colluded with Pfizer Inc. unit King Pharmaceuticals Inc. to delay generic versions of the muscle relaxant Skelaxin, saying it was fair.

13 other articles on this case. View all »

Parties

To view the parties, register now.